• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肺曲霉病——全科医师指南。

Chronic pulmonary aspergillosis - a guide for the general physician.

机构信息

Registrar in respiratory medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Respiratory dietitian, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Clin Med (Lond). 2024 Jan;24(1):100019. doi: 10.1016/j.clinme.2024.100019. Epub 2024 Jan 26.

DOI:10.1016/j.clinme.2024.100019
PMID:38281665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11024841/
Abstract

This collaborative article presents a review of chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.

摘要

这篇合作文章从呼吸科医师、放射科医师、真菌学家、营养师、药剂师、物理治疗师和姑息治疗专家组成的多学科团队的角度,对慢性肺曲霉病(CPA)进行了综述。本文综合了目前关于 CPA 的知识,强调了临床、放射学和微生物学方面之间的复杂相互作用。我们强调了对每个患者进行多学科评估的重要性,以确保制定个性化的治疗策略,并采取整体方法进行患者护理。

相似文献

1
Chronic pulmonary aspergillosis - a guide for the general physician.慢性肺曲霉病——全科医师指南。
Clin Med (Lond). 2024 Jan;24(1):100019. doi: 10.1016/j.clinme.2024.100019. Epub 2024 Jan 26.
2
Chronic pulmonary aspergillosis: an update on diagnosis and treatment.慢性肺曲霉病:诊断与治疗的最新进展
Respiration. 2014;88(2):162-74. doi: 10.1159/000362674. Epub 2014 Jun 17.
3
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.慢性肺曲霉病:诊断和管理的原理和临床指南。
Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.
4
Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.中国患者慢性肺曲霉病的临床特征与诊断
Medicine (Baltimore). 2017 Oct;96(42):e8315. doi: 10.1097/MD.0000000000008315.
5
[Chronic pulmonary aspergillosis].[慢性肺曲霉病]
Nihon Rinsho. 2011 Aug;69(8):1462-7.
6
Chronic pulmonary aspergillosis.慢性肺曲霉病
Mycoses. 2014 May;57(5):257-70. doi: 10.1111/myc.12152. Epub 2013 Dec 2.
7
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.慢性肺曲霉病的基础条件包括单纯性肺曲霉球。
Eur Respir J. 2011 Apr;37(4):865-72. doi: 10.1183/09031936.00054810. Epub 2010 Jul 1.
8
[Invasive pulmonary aspergillosis and chronic pulmonary aspergillosis].[侵袭性肺曲霉病和慢性肺曲霉病]
Rev Med Suisse. 2014 Nov 19;10(451):2202-7.
9
Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.中国慢性肺曲霉病患者的临床特征和转归:一项回顾性、观察性研究。
J Mycol Med. 2020 Dec;30(4):101041. doi: 10.1016/j.mycmed.2020.101041. Epub 2020 Aug 28.
10
Noninvasive pulmonary Aspergillus infections.非侵袭性肺曲霉感染
Clin Chest Med. 2009 Jun;30(2):315-35, vii. doi: 10.1016/j.ccm.2009.02.008.

引用本文的文献

1
A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).肺结核后患者的隐匿威胁:印度尼西亚多个地区慢性肺曲霉病调查(I-CHROME研究)
J Fungi (Basel). 2025 Apr 22;11(5):329. doi: 10.3390/jof11050329.
2
Treat staff like they make a difference, and they will.以员工举足轻重的态度对待他们,他们就会做到举足轻重。
Clin Med (Lond). 2024 Jan;24(1):100018. doi: 10.1016/j.clinme.2024.100018. Epub 2024 Jan 24.

本文引用的文献

1
Global incidence and mortality of severe fungal disease.全球严重真菌感染的发病率和死亡率。
Lancet Infect Dis. 2024 Jul;24(7):e428-e438. doi: 10.1016/S1473-3099(23)00692-8. Epub 2024 Jan 12.
2
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中曲霉菌病的临床特征。
Infection. 2023 Aug;51(4):813-829. doi: 10.1007/s15010-022-01960-2. Epub 2023 Jan 20.
3
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment.
人群基因组学证实,人类耐药烟曲霉感染是从环境中获得的。
Nat Microbiol. 2022 May;7(5):663-674. doi: 10.1038/s41564-022-01091-2. Epub 2022 Apr 25.
4
Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease.伊曲康唑作为慢性肺真菌病挽救治疗的经验
J Fungi (Basel). 2022 Mar 31;8(4):362. doi: 10.3390/jof8040362.
5
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.12 个月口服伊曲康唑对比 6 个月口服伊曲康唑预防慢性肺部曲霉病复发的疗效:印度一项开放标签、随机对照试验。
Lancet Infect Dis. 2022 Jul;22(7):1052-1061. doi: 10.1016/S1473-3099(22)00057-3. Epub 2022 Apr 13.
6
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement.慢性肺曲霉病的治疗结局定义:CPAnet共识声明
Eur Respir J. 2022 Jun 9;59(6). doi: 10.1183/13993003.02950-2021. Print 2022 Jun.
7
Chronic Pulmonary Aspergillosis: A Brief Review.慢性肺曲霉病:简要综述。
Yale J Biol Med. 2021 Dec 29;94(4):673-679. eCollection 2021 Dec.
8
Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases.非洲慢性肺曲霉病的外科治疗:891 例病例的系统评价。
Mycoses. 2021 Oct;64(10):1151-1158. doi: 10.1111/myc.13359. Epub 2021 Aug 15.
9
Healthcare Utilization and Impact of Antifungal Stewardships Within Respiratory Care Settings: A Systematic Literature Review.呼吸系统护理环境中抗真菌药物管理的利用和影响:系统文献回顾。
Mycopathologia. 2021 Oct;186(5):673-684. doi: 10.1007/s11046-021-00547-z. Epub 2021 May 15.
10
World Health Organization 2020 guidelines on physical activity and sedentary behaviour.世界卫生组织 2020 年关于身体活动和 sedentary behaviour 的指南。
Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.